+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurotransmitter"

Epilepsy Drugs - Global Strategic Business Report - Product Thumbnail Image

Epilepsy Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 276 Pages
  • Global
From
Anticholinergic Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticholinergic Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 93 Pages
  • Global
From
Parkinson's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 382 Pages
  • Global
From
Botulinum Toxin - Global Strategic Business Report - Product Thumbnail Image

Botulinum Toxin - Global Strategic Business Report

  • Report
  • October 2025
  • 353 Pages
  • Global
From
Huntington's Disease Treatment Market Report 2025 - Product Thumbnail Image

Huntington's Disease Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Antiepileptic Drugs Market Report 2025 - Product Thumbnail Image

Antiepileptic Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Phenobarbital Market Report 2025 - Product Thumbnail Image

Phenobarbital Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Neurological Disorder Drugs Market Report 2025 - Product Thumbnail Image

Neurological Disorder Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Cholinergic Drugs Market Report 2025 - Product Thumbnail Image

Cholinergic Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Anticholinergic Drugs Market Report 2025 - Product Thumbnail Image

Anticholinergic Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Catecholamines Global Market Report 2025 - Product Thumbnail Image

Catecholamines Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
From
Muscarinic Acetylcholine Receptor Market Report 2025 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Myotonic Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Myotonic Dystrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
5-HT2 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2 Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Ionotropic Glutamate Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Ionotropic Glutamate Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Epilepsy - Pipeline Insight, 2025 - Product Thumbnail Image

Epilepsy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Migraine - Pipeline Insight, 2025 - Product Thumbnail Image

Migraine - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Neurotransmitter market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurotransmitters are chemicals that are released by neurons to send signals to other cells. These drugs are used to treat a variety of neurological disorders, including depression, anxiety, and schizophrenia. Neurotransmitter drugs work by either increasing or decreasing the amount of neurotransmitters in the brain. The Neurotransmitter market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Merck. Other companies such as Novartis, AstraZeneca, and Johnson & Johnson also have a presence in the Neurotransmitter market. Show Less Read more